The examination and diagnosis of geographic atrophy ... monitoring and treatment planning. In clinical trials, it can influence patient selection, study duration, costs and overall outcomes.

A powerful clinical artificial intelligence tool developed ... on all three parts of the United States Medical Licensing Exam (Step exams), according to a paper published today (April 22) in ...

Additionally, if an APGAR score is calculated, how could that information be helpful to the producer? Rather, Homerosky aimed to develop a Beef Calf Vigor Assessment by determining calving ...

While ChatGPT-4 excels at multiple-choice medical exams, new research reveals its weaknesses in complex clinical decision-making, raising big questions about the future of AI-powered healthcare.

Study finds MPS2 scores are highly reproducible across DRE and non-DRE urine samples alike ... prostate cancer risk assessment across diverse clinical workflows." MPS2 is a urine-based test ...

Black patients should be included in shared decision-making with HCPs after screening with PSA and DRE, since they express ... underrepresentation in clinical research, and poor patient-provider ...

Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, announced today the provisional accreditation by the College of Physicians and Surgeons ...

included biopsy-naive adult men with clinical suspicion of prostate cancer due to elevated prostate-specific antigen levels or abnormal findings on digital rectal examination, who were indicated ...

“Thus, to determine the value and impact of the MSDA on clinician decision-making as an adjunct to the clinical exam and MRI findings, the present study examined whether and how clinicians ...